Bill Text: MS SB2582 | 2010 | Regular Session | Introduced


Bill Title: Controlled substance; revise Schedules II and V.

Spectrum: Partisan Bill (Republican 1-0)

Status: (Failed) 2010-02-02 - Died In Committee [SB2582 Detail]

Download: Mississippi-2010-SB2582-Introduced.html

MISSISSIPPI LEGISLATURE

2010 Regular Session

To: Drug Policy

By: Senator(s) Burton

Senate Bill 2582

AN ACT TO AMEND SECTION 41-29-115, MISSISSIPPI CODE OF 1972, TO ADD TAPENTADOL TO SCHEDULE II; TO AMEND SECTION 41-29-121, MISSISSIPPI CODE OF 1972, TO ADD LACOSAMIDE TO SCHEDULE V; AND FOR RELATED PURPOSES.

     BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MISSISSIPPI:

     SECTION 1.  Section 41-29-115, Mississippi Code of 1972, is amended as follows:

     41-29-115.  (A)  The controlled substances listed in this section are included in Schedule II.

SCHEDULE II

          (a)  Any of the following substances, except those narcotic drugs listed in other schedules, whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by combination of extraction and chemical synthesis:

              (1)  Opium and opiate, and any salt, compound, derivative, or preparation of opium or opiate, excluding naloxone hydrochloride, apomorphine, thebaine-derived butorphanol, dextrorphan, nalbuphine, nalmefene and naltrexone, but including the following:

                   (i)  Codeine;

                   (ii)  Dihydroetorphine;

                   (iii)  Ethylmorphine;

                   (iv)  Etorphine hydrochloride;

                   (v)  Granulated opium;

                   (vi)  Hydrocodone;

                   (vii)  Hydromorphone;

                   (viii)  Metopon;

                   (ix)  Morphine;

                   (x)  Opium extracts;

                   (xi)  Opium fluid extracts;

                   (xii)  Oripavine;

                   (xiii)  Oxycodone;

                   (xiv)  Oxymorphone;

                   (xv)  Powdered opium;

                   (xvi)  Raw opium;

                   (xvii)  Thebaine;

                   (xviii)  Tincture of opium.

              (2)  Any salt, compound, isomer, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in paragraph (1), but not including the isoquinoline alkaloids of opium;

              (3)  Opium poppy and poppy straw;

              (4)  Coca leaves and any salt, compound, derivative, or preparation of cocaine or coca leaves, including cocaine and ecgonine and any salt, compound, derivative, isomer, or preparation thereof which is chemically equivalent or identical with any of these substances, but not including decocainized coca leaves or extractions which do not contain cocaine or ecgonine;

              (5)  Concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid or powder form which contains the phenanthrene alkaloids of the opium poppy).

          (b)  Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, whenever the existence of these isomers, esters, ethers and salts is possible within the specified chemical designation, dextrorphan and levopropoxyphene excepted:

              (1)  Alfentanil;

              (2)  Alphaprodine;

              (3)  Anileridine;

              (4)  Bezitramide;

              (5)  Bulk dextropropoxyphene (nondosage forms);

              (6)  Carfentanil;

              (7)  Dihydrocodeine;

              (8)  Diphenoxylate;

              (9)  Fentanyl;

              (10)  Isomethadone;

              (11)  Levo-alphacetylmethadol (levo-alpha-acetylmethadol, levomethadyl acetate, LAAM);

              (12)  Levomethorphan;

              (13)  Levorphanol;

              (14)  Metazocine;

              (15)  Methadone;

              (16)  Methadone-intermediate, 4-cyano-2-dimethylamino-4,4-diphenyl butane;

              (17)  Moramide-intermediate, 2-methyl-3-morpholino-1,1-diphenylpropane-carboxylic acid;

              (18)  Pethidine (meperidine);

              (19)  Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;

              (20)  Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;

              (21)  Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;

              (22)  Phenazocine;

              (23)  Piminodine;

              (24)  Racemethorphan;

              (25)  Racemorphan;

              (26)  Remifentanil;

              (27)  Sufentanil;

              (28)  Tapentadol.

          (c)  Any material, compound, mixture, or preparation which contains any quantity of the following substances:

              (1)  Amphetamine, its salts, optical isomers, and salts of its optical isomers;

              (2)  Phenmetrazine and its salts;

              (3)  Any substance which contains any quantity of methamphetamine, including its salts, isomers, and salts of isomers;

              (4)  Methylphenidate and its salts;

              (5)  Lisdexamfetamine, its salts, isomers and salts of isomers.

          (d)  Unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances:

              (1)  Amobarbital;

              (2)  Secobarbital;

              (3)  Pentobarbital;

              (4)  Amphetamine and methamphetamine immediate precursor:  Phenylacetone (phenyl-2-propanone; P2P; benzyl methyl ketone; and methyl benzyl ketone);

              (5)  Phencyclidine immediate precursors:

                   (i)  1-phenylcyclohexylamine;

                   (ii)  1-piperidinocyclohexanecarbonitrile (PCC);

              (6)  Pentazocine and its salts in injectable dosage form;

              (7)  Nabilone, other names include: (+/-)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a- hexahydro-1-hydroxy-6,6-dimethyl-9H-dibenzo(b,d)pyran-9-one;

              (8)  Glutethimide.

     (B)  Any material, compound, mixture or preparation which contains any quantity of a Schedule II controlled substance and is listed as an exempt substance in 21 CFR, Section 1308.24 or 1308.32, shall be exempted from the provisions of the Uniform Controlled Substances Law.

     SECTION 2.  Section 41-29-121, Mississippi Code of 1972, is amended as follows:

     41-29-121.  (A)  The controlled substances listed in this section are included in Schedule V:

SCHEDULE V

          (a)  Any compound, mixture or preparation containing limited quantities of any of the following narcotic drugs, which also contains one or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture or preparation, valuable, medicinal qualities other than those possessed by the narcotic drug alone:

              (1)  Not more than two hundred (200) milligrams of codeine, or any of its salts, per one hundred (100) milliliters or per one hundred (100) grams;

              (2)  Not more than one hundred (100) milligrams of dihydrocodeine, or any of its salts, per one hundred (100) milliliters or per one hundred (100) grams;

              (3)  Not more than one hundred (100) milligrams of ethylmorphine, or any of its salts, per one hundred (100) milliliters or per one hundred (100) grams;

              (4)  Not more than two and five-tenths (2.5) milligrams of diphenoxylate and not less than twenty-five (25) micrograms of atropine sulphate per dosage unit;

              (5)  Not more than one hundred (100) milligrams of opium per one hundred (100) milliliters or per one hundred (100) grams;

              (6)  Not more than five-tenths (0.5) milligram of difenoxin and not less than twenty-five (25) micrograms of atropine sulfate per dosage unit.

          (b)  Unless specifically excepted or listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances, including their salts, isomers and salts of isomers:

              (1)  Lacosamide [(R)-2-acetoamido-N-benzyl-3-methoxy-propionamide];

              (2)  Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid];

              (3)  Pyrovalerone.

     (B)  Any material, compound, mixture or preparation which contains any quantity of a Schedule V controlled substance and is listed as an exempt substance in 21 CFR, Section 1308.22, 1308.24, 1308.26, 1308.32 or 1308.34, shall be exempted from the provisions of the Uniform Controlled Substances Law.

     SECTION 3.  This act shall take effect and be in force from and after July 1, 2010.


feedback